Publications by authors named "Yu Yagi"

Claim this Profile
E
Efficacy and Safety of Rituximab plus Modified EPOCH (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Transplant-ineligible Relapsed/Refractory Diffuse Large B-cell Lymphoma.
Eriko Fujioka, Junichi Kiyasu, Ilseung Choi, Yu Yagi, Taro Sawabe

Intern Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Added value of inflammatory markers to vital signs for predicting mortality in patients with suspected infection: external validation and model development.
Toshihiko Takada, Jeroen Hoogland, Kotaro Fujii, Masataka Kudo, Sho Sasaki, Yu Yagi

Intern Emerg Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site- and Stage-Adapted Treatment Strategies for Gastrointestinal Diffuse Large B-Cell Lymphoma.
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Mariko Matsubayashi, Yasuhiko Yamamura

Eur J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting 30-day mortality in older patients with suspected infections by adding performance status to quick sequential organ failure assessment.
Masataka Kudo, Sho Sasaki, Toshihiko Takada, Kotaro Fujii, Yu Yagi

J Gen Fam Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Added Value of Shaking Chills for Predicting Bacteremia in Patients with Suspected Infection.
Masataka Kudo, Toshihiko Takada, Kotaro Fujii, Sho Sasaki, Yu Yagi

J Gen Intern Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of HER2-positive and microsatellite instability-high advanced gastric cancer: a case report.
Taichi Tamura, Yusuke Kanemasa, Shohei Nakamura, Toshihiro Okuya, Yu Yagi

Int Cancer Conf J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy.
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Sotaro Goto, Yasuhiko Yamamura

J Clin Exp Hematop· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supplementary Contribution of Eastern Cooperative Oncology Group-Performance Status to Quick Sequential Organ Failure Assessment in the Detection of Bacteremia Among Older Patients With Suspected Infections.
Masataka Kudo, Sho Sasaki, Yu Yagi, Hiroshi Imura

Cureus· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma after second-line salvage chemotherapy: A retrospective study.
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Mina Sei, Takuma Matsuo

Cancer Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant].
Yuka Morita, Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Kento Ishimine

Rinsho Ketsueki· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemoglobin-platelet index as a prognostic factor in patients with peripheral T-cell lymphoma.
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Shunichi Okumura, Takako Watanabe

EJHaem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful dual antiviral therapy with remdesivir and ensitrelvir in a case of prolonged COVID-19 following B-cell depleting immunotherapy for malignant lymphoma.
Seowoong Jung, Yu Yagi, Kazuaki Fukushima, Yukari Nishikawa, Masaru Tanaka

IDCases· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma.
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Sotaro Goto, Yasuhiko Yamamura

Ann Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Performance of Physician Gestalt for Bacteremia in Patients in the Process of Being Admitted With Suspected Infection.
Kotaro Fujii, Toshihiko Takada, Tsukasa Kamitani, Takuya Aoki, Taro Takeshima, Yu Yagi

Clin Infect Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma: real-world data from single institute experience].
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Yudai Hayashi, Mano Mino

Rinsho Ketsueki· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study.
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, An Ohigashi, Yuka Morita

BMC Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma.
Yuka Morita, Yusuke Kanemasa, Yuki Sasaki, An Ohigashi, Taichi Tamura, Yu Yagi

Medicine (Baltimore)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma: A case report.
Yu Yagi, Yusuke Kanemasa, An Ohigashi, Yuka Morita, Taichi Tamura

Medicine (Baltimore)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of food consumption for bacteraemia in patients admitted with suspected infection: a prospective cohort study.
Toshihiko Takada, Kotaro Fujii, Masataka Kudo, Sho Sasaki, Tetsuhiro Yano, Yu Yagi

BMJ Open· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of the Modified EPOCH Regimen (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Adult T-cell Leukemia/Lymphoma: A Multicenter Retrospective Study.
Yasuhiro Tsukamoto, Junichi Kiyasu, Ilseung Choi, Mitsuo Kozuru, Naokuni Uike, Yu Yagi

Clin Lymphoma Myeloma Leuk· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postherpetic abdominal pseudohernia: A diagnostic pitfall.
Yu Yagi, Takashi Matono, Kenichi Nakamura, Hiroshi Imura

J Gen Fam Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis